These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11841600)

  • 1. Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radical.
    Li XJ; Gu J; Lu SD; Sun FY
    J Pineal Res; 2002 Jan; 32(1):47-52. PubMed ID: 11841600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-induced neurotoxicity.
    Mohanakumar KP; Muralikrishnan D; Thomas B
    Brain Res; 2000 May; 864(2):281-90. PubMed ID: 10802035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic human proline-rich-polypeptide enhances hydroxyl radical generation and fails to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced toxicity in mice.
    Knaryan VH; Samantaray S; Galoyan AA; Mohanakumar KP
    Neurosci Lett; 2005 Mar; 375(3):187-91. PubMed ID: 15694258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway.
    Morgan WW; Nelson JF
    Brain Res; 2001 Dec; 921(1-2):115-21. PubMed ID: 11720717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.
    Ago Y; Kawasaki T; Nashida T; Ota Y; Cong Y; Kitamoto M; Takahashi T; Takuma K; Matsuda T
    Neuropharmacology; 2011 Dec; 61(8):1441-51. PubMed ID: 21903118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic bovine proline-rich-polypeptides generate hydroxyl radicals and fail to protect dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in mice.
    Knaryan VH; Samantaray S; Varghese M; Srinivasan A; Galoyan AA; Mohanakumar KP
    Neuropeptides; 2006 Aug; 40(4):291-8. PubMed ID: 16712929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Thomas B; Muralikrishnan D; Mohanakumar KP
    Brain Res; 2000 Jan; 852(1):221-4. PubMed ID: 10661517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA; Kim AR; Kurina AY; Ugrumov MV
    Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D; Samantaray S; Mohanakumar KP
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis.
    Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF
    Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice.
    Blanchet J; Longpré F; Bureau G; Morissette M; DiPaolo T; Bronchti G; Martinoli MG
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1243-50. PubMed ID: 18471948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zonisamide-induced long-lasting recovery of dopaminergic neurons from MPTP-toxicity.
    Choudhury ME; Moritoyo T; Kubo M; Kyaw WT; Yabe H; Nishikawa N; Nagai M; Matsuda S; Nomoto M
    Brain Res; 2011 Apr; 1384():170-8. PubMed ID: 21320474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo generation of hydroxyl radicals and MPTP-induced dopaminergic toxicity in the basal ganglia.
    Chiueh CC; Wu RM; Mohanakumar KP; Sternberger LM; Krishna G; Obata T; Murphy DL
    Ann N Y Acad Sci; 1994 Nov; 738():25-36. PubMed ID: 7832434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 5α-reductase inhibitor Dutasteride but not Finasteride protects dopamine neurons in the MPTP mouse model of Parkinson's disease.
    Litim N; Bourque M; Al Sweidi S; Morissette M; Di Paolo T
    Neuropharmacology; 2015 Oct; 97():86-94. PubMed ID: 26006269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does melatonin help save dopaminergic cells in MPTP-treated mice?
    Ma J; Shaw VE; Mitrofanis J
    Parkinsonism Relat Disord; 2009 May; 15(4):307-14. PubMed ID: 18793863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats.
    Capitelli C; Sereniki A; Lima MM; Reksidler AB; Tufik S; Vital MA
    Eur J Pharmacol; 2008 Oct; 594(1-3):101-8. PubMed ID: 18674531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in goldfish brain.
    Poli A; Guarnieri T; Facchinetti F; Villani L
    Brain Res; 1990 Nov; 534(1-2):45-50. PubMed ID: 1981485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.